Lisa Paschold

2.1k total citations · 1 hit paper
31 papers, 864 citations indexed

About

Lisa Paschold is a scholar working on Infectious Diseases, Oncology and Surgery. According to data from OpenAlex, Lisa Paschold has authored 31 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Oncology and 8 papers in Surgery. Recurrent topics in Lisa Paschold's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Lisa Paschold is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Lisa Paschold collaborates with scholars based in Germany, Switzerland and United States. Lisa Paschold's co-authors include Mascha Binder, Edith Willscher, Christoph Schultheiß, Rebecca A. Porritt, Magali Noval Rivas, Moshe Arditi, İvet Bahar, Mary Hongying Cheng, Jochen Dutzmann and Daniel Sedding and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Lisa Paschold

30 papers receiving 853 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19

2022 256 citations Christoph Schultheiß, Edith Willscher et al. Cell Reports Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Paschold Germany	11	466	312	249	188	109	31	864
Christoph Schultheiß Germany	13	292 0.6×	257 0.8×	99 0.4×	181 1.0×	118 1.1×	37	706
Olha Halyabar United States	7	375 0.8×	209 0.7×	120 0.5×	149 0.8×	169 1.6×	12	727
Анна Старшинова Russia	15	383 0.8×	137 0.4×	171 0.7×	67 0.4×	104 1.0×	113	747
Almina Jukic Austria	6	141 0.3×	145 0.5×	69 0.3×	211 1.1×	83 0.8×	11	558
Sarah Adamo Switzerland	13	329 0.7×	250 0.8×	41 0.2×	109 0.6×	157 1.4×	21	606
Chansavath Phetsouphanh Australia	15	363 0.8×	452 1.4×	38 0.2×	210 1.1×	318 2.9×	24	1.0k
N. Yu. Semenova Russia	9	277 0.6×	176 0.6×	69 0.3×	109 0.6×	55 0.5×	46	552
Seigo Nagashima Brazil	9	294 0.6×	147 0.5×	53 0.2×	164 0.9×	152 1.4×	41	619
Jintao Wang China	7	284 0.6×	153 0.5×	50 0.2×	78 0.4×	99 0.9×	18	507
Jiram Torres‐Ruiz Mexico	19	276 0.6×	150 0.5×	40 0.2×	276 1.5×	430 3.9×	48	895

Countries citing papers authored by Lisa Paschold

Since Specialization

Citations

This map shows the geographic impact of Lisa Paschold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Paschold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Paschold more than expected).

Fields of papers citing papers by Lisa Paschold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Paschold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Paschold. The network helps show where Lisa Paschold may publish in the future.

Co-authorship network of co-authors of Lisa Paschold

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Paschold. A scholar is included among the top collaborators of Lisa Paschold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Paschold. Lisa Paschold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paschold, Lisa, Christoph Schultheiß, Konrad Klinghammer, et al.. (2025). Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer. npj Precision Oncology. 9(1). 272–272.

Schultheiß, Christoph, Lisa Paschold, Rafael Mikolajczyk, et al.. (2025). Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors. Journal of Allergy and Clinical Immunology. 155(5). 1664–1674. 1 indexed citations

Schultheiß, Christoph, Lisa Paschold, Benjamin Thiele, et al.. (2024). T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas. Haematologica. 110(2). 457–469. 2 indexed citations

Thuss‐Patience, Peter, Eray Goekkurt, M. Stahl, et al.. (2024). Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma. JAMA Network Open. 7(1). e2352830–e2352830. 9 indexed citations

Willscher, Edith, Lisa Paschold, Cornelia Gottschick, et al.. (2024). SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition. npj Vaccines. 9(1). 23–23. 5 indexed citations

Kalweit, Gabriel, Lisa Paschold, Christoph Schultheiß, et al.. (2024). Detection of disease-specific signatures in B cell repertoires of lymphomas using machine learning. PLoS Computational Biology. 20(7). e1011570–e1011570. 4 indexed citations

Thiele, Benjamin, Alexander Stein, Christoph Schultheiß, et al.. (2024). Trifluridine/Tipiracil Based Chemoradiation in locally Advanced Rectal Cancer: The Phase I/II TARC Trial. Clinical Colorectal Cancer. 24(1). 11–17. 2 indexed citations

Paschold, Lisa, Thomas Weber, Richard Brill, et al.. (2023). No association of malignant B‐cell non‐Hodgkin lymphomas with ipsilateral SARS‐CoV‐2 vaccination. Cancer Medicine. 12(8). 9313–9321. 1 indexed citations

Paschold, Lisa, Alexander Stein, Benjamin Thiele, et al.. (2023). First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial. Journal for ImmunoTherapy of Cancer. 11(6). e006678–e006678. 8 indexed citations

10.

Paschold, Lisa, Bianca Klee, Cornelia Gottschick, et al.. (2022). Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination. Frontiers in Immunology. 13. 876306–876306. 13 indexed citations

11.

Schultheiß, Christoph, Rebekka Scholz, Lisa Paschold, et al.. (2022). PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition. Frontiers in Oncology. 12. 941666–941666. 1 indexed citations

12.

Schultheiß, Christoph, Edith Willscher, Lisa Paschold, et al.. (2022). The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Reports Medicine. 3(6). 100663–100663. 256 indexed citations breakdown →

13.

Grimm, Juliane, Donjetë Simnica, Nadja Jäkel, et al.. (2022). Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients. Blood Cancer Journal. 12(1). 19–19. 11 indexed citations

14.

Schultheiß, Christoph, Edith Willscher, Lisa Paschold, et al.. (2022). Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19. Journal of Medical Virology. 95(1). e28364–e28364. 52 indexed citations

15.

Porritt, Rebecca A., Lisa Paschold, Magali Noval Rivas, et al.. (2021). HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. Journal of Clinical Investigation. 131(10). 99 indexed citations

16.

Porritt, Rebecca A., Aleksandra Binek, Lisa Paschold, et al.. (2021). The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. Journal of Clinical Investigation. 131(20). 86 indexed citations

17.

Paschold, Lisa, Edith Willscher, Martine Vornanen, et al.. (2021). Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation. Haematologica. 106(10). 2654–2666. 10 indexed citations

18.

Schultheiß, Christoph, Lisa Paschold, Edith Willscher, et al.. (2021). Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19. iScience. 24(11). 103325–103325. 26 indexed citations

19.

Cheng, Mary Hongying, She Zhang, Rebecca A. Porritt, et al.. (2020). Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proceedings of the National Academy of Sciences. 117(41). 25254–25262. 206 indexed citations

20.

Bauer, Marcus, Lisa Paschold, Claudia Wickenhauser, et al.. (2020). Impact of bone marrow involvement on outcome in relapsed and refractory transplant eligible diffuse large B-cell lymphoma and transformed indolent lymphoma. PLoS ONE. 15(7). e0235786–e0235786. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact